SCHEDULE: Vanguard Group Shifts QuidelOrtho Stake Reporting

The Vanguard Group reports 0% beneficial ownership in QuidelOrtho Corp following an internal realignment, with subsidiaries now reporting separately.

Summary

• The Vanguard Group filed an Amendment No. 6 to Schedule 13G for QuidelOrtho Corp, indicating a change in its beneficial ownership.
• The filing states that The Vanguard Group now beneficially owns 0 shares, representing 0% of QuidelOrtho Corp's Common Stock.
• This change is a result of an internal realignment within The Vanguard Group, Inc. that occurred on January 12, 2026.
• Following the realignment, certain subsidiaries or business divisions of The Vanguard Group, Inc. will now report their beneficial ownership separately on a disaggregated basis, in reliance on SEC Release No. 34-39538 (January 12, 1998).
• Consequently, The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over the securities now reported by these subsidiaries.
• The event requiring this filing occurred on March 13, 2026, and the filing was signed on March 27, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative update. The change in beneficial ownership reporting by Vanguard is due to an internal realignment and does not reflect a change in investment thesis regarding QuidelOrtho Corp.

Future Outlook

No forward-looking statements or guidance for QuidelOrtho Corp are provided in this filing.

Industry Context

StockSavvy.ai notes that such disaggregated reporting by large institutional investors like Vanguard is a common practice, especially after internal reorganizations, to comply with SEC regulations regarding beneficial ownership. It reflects an administrative change in reporting structure rather than a strategic divestment from the underlying asset.

Comparison to Industry Standards

• This filing is an administrative update by a large asset manager, The Vanguard Group, concerning its beneficial ownership reporting.
• The change in reporting structure, moving to a disaggregated basis for subsidiaries, aligns with standard practices for large investment firms undergoing internal restructuring, as permitted by SEC guidance (e.g., SEC Release No. 34-39538).

Stakeholder Impact

• Shareholders of QuidelOrtho Corp: The underlying ownership by Vanguard-managed funds may still exist, but the aggregate reporting under 'The Vanguard Group' has changed. This clarifies who is now responsible for reporting those holdings.
• Regulatory bodies: The filing ensures compliance with SEC reporting requirements for beneficial ownership following an internal corporate restructuring.

Next Steps

• Vanguard's subsidiaries or business divisions are expected to report their beneficial ownership of QuidelOrtho Corp securities separately.

Key Dates

Recommendation

The filing details an administrative change in how The Vanguard Group reports its beneficial ownership in QuidelOrtho Corp, moving to a disaggregated reporting model through its subsidiaries. This is not a strategic divestment based on QuidelOrtho's performance but an internal restructuring by Vanguard. Therefore, it provides no new fundamental information to alter an existing investment thesis, warranting a 'hold' recommendation.

Keywords

Vanguard Group, QuidelOrtho Corp, Schedule 13G, Beneficial Ownership, SEC Filing, Institutional Investor, Common Stock, Ownership Change, Internal Realignment